Niagen Bioscience Inc (NAGE)

EBITDA

$1.17M

Quarterly · Period ending: · USD

NAGE logo

NAGE EBITDA

Latest reported$1.17M
NAGE Quarterly EBITDA (-$12.55K → $1.17M)
High-resolution chart · PNG

NAGE ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Niagen Bioscience Inc EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
1,170,000
7,199,000
4,792,000
5,159,000
4,092,000
5,599,000
7,842,000
2,244,000
355,000
-102,000
487,000
-511,000
-1,747,000
-1,462,000
-3,074,000
-531,000
-5,956,000
-7,183,000
-4,928,000
-8,425,000
-5,139,000
-6,955,000
-5,686,000
-3,819,000
-3,314,000
-5,522,000
-8,503,000
-6,486,000
-6,788,000
-8,000,000
-8,009,000
-8,368,000
-7,733,000
-8,220,000
-8,605,647
-2,986,000
-2,449,000
-1,620,000
-2,001,629
-824,423
475,099
548,677
-1,151,272
262,276
-102,621
-828,340
-1,031,112
-583,211
-1,577,130
-1,779,573
-649,294
-1,182,054
-952,007
-1,332,133
-1,604,014
-1,446,212
-3,901,661
-4,334,776
-2,387,804
-2,297,546
-1,732,391
-1,047,617
-790,030
-774,223
-197,331
131,843
-12,732
-76,563
-187,628
-221,308
-527,289
-603,389
-625,952
-2,928
-3,545
-4,302
-2,910
-12,550
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.